0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Gonadorelin Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-38B14840
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Veterinary Gonadorelin Injection Market Research Report 2023
BUY CHAPTERS

Global Veterinary Gonadorelin Injection Market Research Report 2025

Code: QYRE-Auto-38B14840
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Gonadorelin Injection Market

The global market for Veterinary Gonadorelin Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Veterinary Gonadorelin Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Veterinary Gonadorelin Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Veterinary Gonadorelin Injection include Zoetis, Merck Animal Health, BELAGROGEN, MSD Animal Health, Boehringer Ingelheim Animal Health, DONG BANG Corporate, BELAGROGEN, Brovapharma, Rooyan Darou, Anhui Fengyuan Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Gonadorelin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Gonadorelin Injection.
The Veterinary Gonadorelin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Gonadorelin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Gonadorelin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Gonadorelin Injection Market Report

Report Metric Details
Report Name Veterinary Gonadorelin Injection Market
Segment by Type
  • 100μg/ml
  • 200μg/ml
  • 300μg/ml
  • 400μg/ml
  • 500μg/ml
  • Others
Segment by Application
  • Ox
  • Pig
  • Dog
  • Horse
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Merck Animal Health, BELAGROGEN, MSD Animal Health, Boehringer Ingelheim Animal Health, DONG BANG Corporate, Brovapharma, Rooyan Darou, Anhui Fengyuan Pharmaceutical, Shanghai Jisheng Biotechnology, Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical, Qilu Animal Health Products, Pai Peptide Biochemical Technology, ESTEVE
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Gonadorelin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary Gonadorelin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Veterinary Gonadorelin Injection Market report?

Ans: The main players in the Veterinary Gonadorelin Injection Market are Zoetis, Merck Animal Health, BELAGROGEN, MSD Animal Health, Boehringer Ingelheim Animal Health, DONG BANG Corporate, Brovapharma, Rooyan Darou, Anhui Fengyuan Pharmaceutical, Shanghai Jisheng Biotechnology, Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical, Qilu Animal Health Products, Pai Peptide Biochemical Technology, ESTEVE

What are the Application segmentation covered in the Veterinary Gonadorelin Injection Market report?

Ans: The Applications covered in the Veterinary Gonadorelin Injection Market report are Ox, Pig, Dog, Horse, Others

What are the Type segmentation covered in the Veterinary Gonadorelin Injection Market report?

Ans: The Types covered in the Veterinary Gonadorelin Injection Market report are 100μg/ml, 200μg/ml, 300μg/ml, 400μg/ml, 500μg/ml, Others

Recommended Reports

Veterinary Reproductive Drugs

Animal Health Solutions

Livestock Diagnostics & Vaccines

1 Veterinary Gonadorelin Injection Market Overview
1.1 Product Definition
1.2 Veterinary Gonadorelin Injection by Type
1.2.1 Global Veterinary Gonadorelin Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 100μg/ml
1.2.3 200μg/ml
1.2.4 300μg/ml
1.2.5 400μg/ml
1.2.6 500μg/ml
1.2.7 Others
1.3 Veterinary Gonadorelin Injection by Application
1.3.1 Global Veterinary Gonadorelin Injection Market Value by Application (2024 VS 2031)
1.3.2 Ox
1.3.3 Pig
1.3.4 Dog
1.3.5 Horse
1.3.6 Others
1.4 Global Veterinary Gonadorelin Injection Market Size Estimates and Forecasts
1.4.1 Global Veterinary Gonadorelin Injection Revenue 2020-2031
1.4.2 Global Veterinary Gonadorelin Injection Sales 2020-2031
1.4.3 Global Veterinary Gonadorelin Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Veterinary Gonadorelin Injection Market Competition by Manufacturers
2.1 Global Veterinary Gonadorelin Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Veterinary Gonadorelin Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Veterinary Gonadorelin Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Veterinary Gonadorelin Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Gonadorelin Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Gonadorelin Injection, Product Type & Application
2.7 Global Key Manufacturers of Veterinary Gonadorelin Injection, Date of Enter into This Industry
2.8 Global Veterinary Gonadorelin Injection Market Competitive Situation and Trends
2.8.1 Global Veterinary Gonadorelin Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary Gonadorelin Injection Players Market Share by Revenue
2.8.3 Global Veterinary Gonadorelin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Gonadorelin Injection Market Scenario by Region
3.1 Global Veterinary Gonadorelin Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Veterinary Gonadorelin Injection Sales by Region: 2020-2031
3.2.1 Global Veterinary Gonadorelin Injection Sales by Region: 2020-2025
3.2.2 Global Veterinary Gonadorelin Injection Sales by Region: 2026-2031
3.3 Global Veterinary Gonadorelin Injection Revenue by Region: 2020-2031
3.3.1 Global Veterinary Gonadorelin Injection Revenue by Region: 2020-2025
3.3.2 Global Veterinary Gonadorelin Injection Revenue by Region: 2026-2031
3.4 North America Veterinary Gonadorelin Injection Market Facts & Figures by Country
3.4.1 North America Veterinary Gonadorelin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Veterinary Gonadorelin Injection Sales by Country (2020-2031)
3.4.3 North America Veterinary Gonadorelin Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Gonadorelin Injection Market Facts & Figures by Country
3.5.1 Europe Veterinary Gonadorelin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Veterinary Gonadorelin Injection Sales by Country (2020-2031)
3.5.3 Europe Veterinary Gonadorelin Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Gonadorelin Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Gonadorelin Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Veterinary Gonadorelin Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Veterinary Gonadorelin Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Veterinary Gonadorelin Injection Market Facts & Figures by Country
3.7.1 Latin America Veterinary Gonadorelin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Veterinary Gonadorelin Injection Sales by Country (2020-2031)
3.7.3 Latin America Veterinary Gonadorelin Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Gonadorelin Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Gonadorelin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Veterinary Gonadorelin Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Veterinary Gonadorelin Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Gonadorelin Injection Sales by Type (2020-2031)
4.1.1 Global Veterinary Gonadorelin Injection Sales by Type (2020-2025)
4.1.2 Global Veterinary Gonadorelin Injection Sales by Type (2026-2031)
4.1.3 Global Veterinary Gonadorelin Injection Sales Market Share by Type (2020-2031)
4.2 Global Veterinary Gonadorelin Injection Revenue by Type (2020-2031)
4.2.1 Global Veterinary Gonadorelin Injection Revenue by Type (2020-2025)
4.2.2 Global Veterinary Gonadorelin Injection Revenue by Type (2026-2031)
4.2.3 Global Veterinary Gonadorelin Injection Revenue Market Share by Type (2020-2031)
4.3 Global Veterinary Gonadorelin Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Veterinary Gonadorelin Injection Sales by Application (2020-2031)
5.1.1 Global Veterinary Gonadorelin Injection Sales by Application (2020-2025)
5.1.2 Global Veterinary Gonadorelin Injection Sales by Application (2026-2031)
5.1.3 Global Veterinary Gonadorelin Injection Sales Market Share by Application (2020-2031)
5.2 Global Veterinary Gonadorelin Injection Revenue by Application (2020-2031)
5.2.1 Global Veterinary Gonadorelin Injection Revenue by Application (2020-2025)
5.2.2 Global Veterinary Gonadorelin Injection Revenue by Application (2026-2031)
5.2.3 Global Veterinary Gonadorelin Injection Revenue Market Share by Application (2020-2031)
5.3 Global Veterinary Gonadorelin Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Veterinary Gonadorelin Injection Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Animal Health Veterinary Gonadorelin Injection Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 BELAGROGEN
6.3.1 BELAGROGEN Company Information
6.3.2 BELAGROGEN Description and Business Overview
6.3.3 BELAGROGEN Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BELAGROGEN Veterinary Gonadorelin Injection Product Portfolio
6.3.5 BELAGROGEN Recent Developments/Updates
6.4 MSD Animal Health
6.4.1 MSD Animal Health Company Information
6.4.2 MSD Animal Health Description and Business Overview
6.4.3 MSD Animal Health Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MSD Animal Health Veterinary Gonadorelin Injection Product Portfolio
6.4.5 MSD Animal Health Recent Developments/Updates
6.5 Boehringer Ingelheim Animal Health
6.5.1 Boehringer Ingelheim Animal Health Company Information
6.5.2 Boehringer Ingelheim Animal Health Description and Business Overview
6.5.3 Boehringer Ingelheim Animal Health Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boehringer Ingelheim Animal Health Veterinary Gonadorelin Injection Product Portfolio
6.5.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
6.6 DONG BANG Corporate
6.6.1 DONG BANG Corporate Company Information
6.6.2 DONG BANG Corporate Description and Business Overview
6.6.3 DONG BANG Corporate Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 DONG BANG Corporate Veterinary Gonadorelin Injection Product Portfolio
6.6.5 DONG BANG Corporate Recent Developments/Updates
6.7 BELAGROGEN
6.7.1 BELAGROGEN Company Information
6.7.2 BELAGROGEN Description and Business Overview
6.7.3 BELAGROGEN Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BELAGROGEN Veterinary Gonadorelin Injection Product Portfolio
6.7.5 BELAGROGEN Recent Developments/Updates
6.8 Brovapharma
6.8.1 Brovapharma Company Information
6.8.2 Brovapharma Description and Business Overview
6.8.3 Brovapharma Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Brovapharma Veterinary Gonadorelin Injection Product Portfolio
6.8.5 Brovapharma Recent Developments/Updates
6.9 Rooyan Darou
6.9.1 Rooyan Darou Company Information
6.9.2 Rooyan Darou Description and Business Overview
6.9.3 Rooyan Darou Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Rooyan Darou Veterinary Gonadorelin Injection Product Portfolio
6.9.5 Rooyan Darou Recent Developments/Updates
6.10 Anhui Fengyuan Pharmaceutical
6.10.1 Anhui Fengyuan Pharmaceutical Company Information
6.10.2 Anhui Fengyuan Pharmaceutical Description and Business Overview
6.10.3 Anhui Fengyuan Pharmaceutical Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Anhui Fengyuan Pharmaceutical Veterinary Gonadorelin Injection Product Portfolio
6.10.5 Anhui Fengyuan Pharmaceutical Recent Developments/Updates
6.11 Shanghai Jisheng Biotechnology
6.11.1 Shanghai Jisheng Biotechnology Company Information
6.11.2 Shanghai Jisheng Biotechnology Description and Business Overview
6.11.3 Shanghai Jisheng Biotechnology Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai Jisheng Biotechnology Veterinary Gonadorelin Injection Product Portfolio
6.11.5 Shanghai Jisheng Biotechnology Recent Developments/Updates
6.12 Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical
6.12.1 Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical Company Information
6.12.2 Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical Description and Business Overview
6.12.3 Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical Veterinary Gonadorelin Injection Product Portfolio
6.12.5 Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical Recent Developments/Updates
6.13 Qilu Animal Health Products
6.13.1 Qilu Animal Health Products Company Information
6.13.2 Qilu Animal Health Products Description and Business Overview
6.13.3 Qilu Animal Health Products Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Qilu Animal Health Products Veterinary Gonadorelin Injection Product Portfolio
6.13.5 Qilu Animal Health Products Recent Developments/Updates
6.14 Pai Peptide Biochemical Technology
6.14.1 Pai Peptide Biochemical Technology Company Information
6.14.2 Pai Peptide Biochemical Technology Description and Business Overview
6.14.3 Pai Peptide Biochemical Technology Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Pai Peptide Biochemical Technology Veterinary Gonadorelin Injection Product Portfolio
6.14.5 Pai Peptide Biochemical Technology Recent Developments/Updates
6.15 ESTEVE
6.15.1 ESTEVE Company Information
6.15.2 ESTEVE Description and Business Overview
6.15.3 ESTEVE Veterinary Gonadorelin Injection Sales, Revenue and Gross Margin (2020-2025)
6.15.4 ESTEVE Veterinary Gonadorelin Injection Product Portfolio
6.15.5 ESTEVE Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Gonadorelin Injection Industry Chain Analysis
7.2 Veterinary Gonadorelin Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Gonadorelin Injection Production Mode & Process Analysis
7.4 Veterinary Gonadorelin Injection Sales and Marketing
7.4.1 Veterinary Gonadorelin Injection Sales Channels
7.4.2 Veterinary Gonadorelin Injection Distributors
7.5 Veterinary Gonadorelin Injection Customer Analysis
8 Veterinary Gonadorelin Injection Market Dynamics
8.1 Veterinary Gonadorelin Injection Industry Trends
8.2 Veterinary Gonadorelin Injection Market Drivers
8.3 Veterinary Gonadorelin Injection Market Challenges
8.4 Veterinary Gonadorelin Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Veterinary Gonadorelin Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Veterinary Gonadorelin Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Veterinary Gonadorelin Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Veterinary Gonadorelin Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Veterinary Gonadorelin Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Veterinary Gonadorelin Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Veterinary Gonadorelin Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Veterinary Gonadorelin Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Veterinary Gonadorelin Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Veterinary Gonadorelin Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Veterinary Gonadorelin Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Veterinary Gonadorelin Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary Gonadorelin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Gonadorelin Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Gonadorelin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Veterinary Gonadorelin Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Veterinary Gonadorelin Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Veterinary Gonadorelin Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Veterinary Gonadorelin Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Veterinary Gonadorelin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Veterinary Gonadorelin Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Veterinary Gonadorelin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Veterinary Gonadorelin Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Veterinary Gonadorelin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Veterinary Gonadorelin Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Veterinary Gonadorelin Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Veterinary Gonadorelin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Veterinary Gonadorelin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Veterinary Gonadorelin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Veterinary Gonadorelin Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Veterinary Gonadorelin Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Veterinary Gonadorelin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Veterinary Gonadorelin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Veterinary Gonadorelin Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Veterinary Gonadorelin Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Veterinary Gonadorelin Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Veterinary Gonadorelin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Veterinary Gonadorelin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Veterinary Gonadorelin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Veterinary Gonadorelin Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Veterinary Gonadorelin Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Veterinary Gonadorelin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Veterinary Gonadorelin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Veterinary Gonadorelin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Veterinary Gonadorelin Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Veterinary Gonadorelin Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Veterinary Gonadorelin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Veterinary Gonadorelin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Veterinary Gonadorelin Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Veterinary Gonadorelin Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Veterinary Gonadorelin Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Veterinary Gonadorelin Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Veterinary Gonadorelin Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Veterinary Gonadorelin Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Veterinary Gonadorelin Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Veterinary Gonadorelin Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Veterinary Gonadorelin Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Veterinary Gonadorelin Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Veterinary Gonadorelin Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Veterinary Gonadorelin Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Veterinary Gonadorelin Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Veterinary Gonadorelin Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Veterinary Gonadorelin Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Veterinary Gonadorelin Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Veterinary Gonadorelin Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Veterinary Gonadorelin Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Veterinary Gonadorelin Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Veterinary Gonadorelin Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Zoetis Company Information
 Table 71. Zoetis Description and Business Overview
 Table 72. Zoetis Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Zoetis Veterinary Gonadorelin Injection Product
 Table 74. Zoetis Recent Developments/Updates
 Table 75. Merck Animal Health Company Information
 Table 76. Merck Animal Health Description and Business Overview
 Table 77. Merck Animal Health Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Merck Animal Health Veterinary Gonadorelin Injection Product
 Table 79. Merck Animal Health Recent Developments/Updates
 Table 80. BELAGROGEN Company Information
 Table 81. BELAGROGEN Description and Business Overview
 Table 82. BELAGROGEN Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BELAGROGEN Veterinary Gonadorelin Injection Product
 Table 84. BELAGROGEN Recent Developments/Updates
 Table 85. MSD Animal Health Company Information
 Table 86. MSD Animal Health Description and Business Overview
 Table 87. MSD Animal Health Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. MSD Animal Health Veterinary Gonadorelin Injection Product
 Table 89. MSD Animal Health Recent Developments/Updates
 Table 90. Boehringer Ingelheim Animal Health Company Information
 Table 91. Boehringer Ingelheim Animal Health Description and Business Overview
 Table 92. Boehringer Ingelheim Animal Health Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Boehringer Ingelheim Animal Health Veterinary Gonadorelin Injection Product
 Table 94. Boehringer Ingelheim Animal Health Recent Developments/Updates
 Table 95. DONG BANG Corporate Company Information
 Table 96. DONG BANG Corporate Description and Business Overview
 Table 97. DONG BANG Corporate Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. DONG BANG Corporate Veterinary Gonadorelin Injection Product
 Table 99. DONG BANG Corporate Recent Developments/Updates
 Table 100. BELAGROGEN Company Information
 Table 101. BELAGROGEN Description and Business Overview
 Table 102. BELAGROGEN Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. BELAGROGEN Veterinary Gonadorelin Injection Product
 Table 104. BELAGROGEN Recent Developments/Updates
 Table 105. Brovapharma Company Information
 Table 106. Brovapharma Description and Business Overview
 Table 107. Brovapharma Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Brovapharma Veterinary Gonadorelin Injection Product
 Table 109. Brovapharma Recent Developments/Updates
 Table 110. Rooyan Darou Company Information
 Table 111. Rooyan Darou Description and Business Overview
 Table 112. Rooyan Darou Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Rooyan Darou Veterinary Gonadorelin Injection Product
 Table 114. Rooyan Darou Recent Developments/Updates
 Table 115. Anhui Fengyuan Pharmaceutical Company Information
 Table 116. Anhui Fengyuan Pharmaceutical Description and Business Overview
 Table 117. Anhui Fengyuan Pharmaceutical Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Anhui Fengyuan Pharmaceutical Veterinary Gonadorelin Injection Product
 Table 119. Anhui Fengyuan Pharmaceutical Recent Developments/Updates
 Table 120. Shanghai Jisheng Biotechnology Company Information
 Table 121. Shanghai Jisheng Biotechnology Description and Business Overview
 Table 122. Shanghai Jisheng Biotechnology Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Shanghai Jisheng Biotechnology Veterinary Gonadorelin Injection Product
 Table 124. Shanghai Jisheng Biotechnology Recent Developments/Updates
 Table 125. Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical Company Information
 Table 126. Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical Description and Business Overview
 Table 127. Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical Veterinary Gonadorelin Injection Product
 Table 129. Shanghai Quanyu Biotechnology (Zhumadian) Pharmaceutical Recent Developments/Updates
 Table 130. Qilu Animal Health Products Company Information
 Table 131. Qilu Animal Health Products Description and Business Overview
 Table 132. Qilu Animal Health Products Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Qilu Animal Health Products Veterinary Gonadorelin Injection Product
 Table 134. Qilu Animal Health Products Recent Developments/Updates
 Table 135. Pai Peptide Biochemical Technology Company Information
 Table 136. Pai Peptide Biochemical Technology Description and Business Overview
 Table 137. Pai Peptide Biochemical Technology Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Pai Peptide Biochemical Technology Veterinary Gonadorelin Injection Product
 Table 139. Pai Peptide Biochemical Technology Recent Developments/Updates
 Table 140. ESTEVE Company Information
 Table 141. ESTEVE Description and Business Overview
 Table 142. ESTEVE Veterinary Gonadorelin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. ESTEVE Veterinary Gonadorelin Injection Product
 Table 144. ESTEVE Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Veterinary Gonadorelin Injection Distributors List
 Table 148. Veterinary Gonadorelin Injection Customers List
 Table 149. Veterinary Gonadorelin Injection Market Trends
 Table 150. Veterinary Gonadorelin Injection Market Drivers
 Table 151. Veterinary Gonadorelin Injection Market Challenges
 Table 152. Veterinary Gonadorelin Injection Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Gonadorelin Injection
 Figure 2. Global Veterinary Gonadorelin Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Veterinary Gonadorelin Injection Market Share by Type: 2024 & 2031
 Figure 4. 100μg/ml Product Picture
 Figure 5. 200μg/ml Product Picture
 Figure 6. 300μg/ml Product Picture
 Figure 7. 400μg/ml Product Picture
 Figure 8. 500μg/ml Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Veterinary Gonadorelin Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Veterinary Gonadorelin Injection Market Share by Application: 2024 & 2031
 Figure 12. Ox
 Figure 13. Pig
 Figure 14. Dog
 Figure 15. Horse
 Figure 16. Others
 Figure 17. Global Veterinary Gonadorelin Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Veterinary Gonadorelin Injection Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Veterinary Gonadorelin Injection Sales (2020-2031) & (K Units)
 Figure 20. Global Veterinary Gonadorelin Injection Average Price (US$/Unit) & (2020-2031)
 Figure 21. Veterinary Gonadorelin Injection Report Years Considered
 Figure 22. Veterinary Gonadorelin Injection Sales Share by Manufacturers in 2024
 Figure 23. Global Veterinary Gonadorelin Injection Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Veterinary Gonadorelin Injection Players: Market Share by Revenue in Veterinary Gonadorelin Injection in 2024
 Figure 25. Veterinary Gonadorelin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Veterinary Gonadorelin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Veterinary Gonadorelin Injection Sales Market Share by Country (2020-2031)
 Figure 28. North America Veterinary Gonadorelin Injection Revenue Market Share by Country (2020-2031)
 Figure 29. United States Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Veterinary Gonadorelin Injection Sales Market Share by Country (2020-2031)
 Figure 32. Europe Veterinary Gonadorelin Injection Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Veterinary Gonadorelin Injection Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Veterinary Gonadorelin Injection Revenue Market Share by Region (2020-2031)
 Figure 40. China Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. China Taiwan Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Southeast Asia Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Veterinary Gonadorelin Injection Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Veterinary Gonadorelin Injection Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Veterinary Gonadorelin Injection Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Veterinary Gonadorelin Injection Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Veterinary Gonadorelin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Veterinary Gonadorelin Injection by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Veterinary Gonadorelin Injection by Type (2020-2031)
 Figure 59. Global Veterinary Gonadorelin Injection Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Veterinary Gonadorelin Injection by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Veterinary Gonadorelin Injection by Application (2020-2031)
 Figure 62. Global Veterinary Gonadorelin Injection Price (US$/Unit) by Application (2020-2031)
 Figure 63. Veterinary Gonadorelin Injection Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools